Connection

ANEES BANDAY to Hypoglycemic Agents

This is a "connection" page, showing publications ANEES BANDAY has written about Hypoglycemic Agents.
Connection Strength

0.637
  1. Chronic insulin treatment phosphorylates the renal Na-K-ATPase a1-subunit at serine 16/23 and reduces its activity involving PI3-kinase-dependent PKC activation. Am J Physiol Renal Physiol. 2016 11 01; 311(5):F958-F966.
    View in: PubMed
    Score: 0.403
  2. Insulin treatment enhances AT1 receptor function in OK cells. Am J Physiol Renal Physiol. 2005 Jun; 288(6):F1213-9.
    View in: PubMed
    Score: 0.181
  3. Renal dopamine D(1) receptor dysfunction is acquired and not inherited in obese Zucker rats. Am J Physiol Renal Physiol. 2004 Jul; 287(1):F109-16.
    View in: PubMed
    Score: 0.043
  4. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats. Hypertension. 2002 Dec; 40(6):880-5.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.